RECURRENCE AFTER ANTICOAGULANT CESSATION IN UNPROVOKED VENOUS THROMBOEMBOLISM: IMPACT OF DEATH AS A COMPETING OUTCOME
Yayun Xu(Renji Hospital), Grégoire Le Gal(University of Ottawa), Isabelle Chagnon(Université de Montréal), Faizan Khan(University of Ottawa), Elham Sabri(Ottawa Hospital), Marc Carrier(University of Ottawa), Susan R. Kahn(Jewish General Hospital), Mark Crowther(Population Health Research Institute), Marc Rodger(McGill University), Richard White(University Hospital of Wales), Philip Wells(University of Ottawa), David R. Anderson(Dalhousie University), M.J. Kovacs, Marc Righini(University Hospital of Geneva)
Cited by 0
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Evidence-Based Management of Anticoagulant Therapy
|CHEST Journal|2012|1.3k
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
|New England Journal of Medicine|2015|1k
Treatment and Prevention of Heparin-Induced Thrombocytopenia
|CHEST Journal|2012|1k